EPIRUBICIN FOR PRETREATED ADVANCED OVARIAN-CANCER

被引：13

作者：

COLEMAN, R

TOWLSON, K

WILTSHAW, E

SLEVIN, M

BLAKE, P

STEIN, R

COOMBES, R

HARPER, P

机构：

[1] GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND

[2] ROYAL MARSDEN HOSP,FULHAM,ENGLAND

[3] HOMERTON HOSP,LONDON,ENGLAND

[4] ST GEORGE HOSP,LONDON,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER | 1990年 / 26卷 / 07期

关键词：

D O I：

10.1016/0277-5379(90)90173-Q

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：850 / 851

页数：2

共 10 条

[1]

DEPALO GM, 1975, SURG GYNECOL OBSTET, V141, P899

[2] CLINICAL TOXICITY OF 4'-EPI-DOXORUBICIN (EPIRUBICIN) [J].

GANZINA, F ;

DIPIETRO, N ;

MAGNI, O .

TUMORI, 1985, 71 (03) :233-240

[3]

HUBBARD SM, 1978, CANCER TREAT REP, V62, P1375

[4] A PROSPECTIVE RANDOMIZED COMPARISON OF EPIRUBICIN AND DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER [J].

JAIN, KK ;

CASPER, ES ;

GELLER, NL ;

HAKES, TB ;

KAUFMAN, RJ ;

CURRIE, V ;

SCHWARTZ, W ;

CASSIDY, C ;

PETRONI, GR ;

YOUNG, CW ;

WITTES, RE .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) :818-826

[5]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[6]

2-6

[7]

ROSSO R, 1985, P ASCO, V4, P113

[8]

TROPE C, 1982, ANTHRACYCLINES CANCE, P216

[9]

VANOOSTEROM AT, 1986, ESMO P, P297

[10]

WHO OFFSET PUBLICATI, V48

← 1 →